Terumo (OTCMKTS:TRUMY) Shares Gap Down – Here’s What Happened

Terumo Corp. (OTCMKTS:TRUMY)’s stock price gapped down prior to trading on Friday . The stock had previously closed at $14.24, but opened at $13.7050. Terumo shares last traded at $13.66, with a volume of 33,835 shares traded.

Analysts Set New Price Targets

A number of brokerages have issued reports on TRUMY. Nomura raised Terumo to a “hold” rating in a research note on Tuesday, February 24th. Zacks Research raised Terumo to a “hold” rating in a research note on Thursday, April 9th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat, Terumo presently has an average rating of “Hold”.

Terumo Stock Down 3.5%

The firm has a market capitalization of $20.27 billion, a price-to-earnings ratio of 22.53 and a beta of 0.67. The company has a current ratio of 1.59, a quick ratio of 0.89 and a debt-to-equity ratio of 0.06. The firm has a 50 day moving average price of $13.67 and a two-hundred day moving average price of $13.81.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings data on Friday, May 15th. The company reported $0.11 earnings per share for the quarter, meeting the consensus estimate of $0.11. The business had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.84 billion. Terumo had a return on equity of 9.17% and a net margin of 12.09%. On average, equities analysts expect that Terumo Corp. will post 0.63 earnings per share for the current fiscal year.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.